Patents by Inventor Ines Macias-Perez

Ines Macias-Perez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR THE PREVENTION OR TREATMENT OF ANTHRAX INFECTION
    Publication number: 20240024411
    Abstract: Methods for preventing or treating a Bacillus anthracis (anthrax) infection in a subject, such as a mammal, by administering to the subject telavancin or a pharmaceutically-acceptable salt thereof.
    Type: Application
    Filed: November 22, 2022
    Publication date: January 25, 2024
    Applicant: Cumberland Pharmaceuticals Inc.
    Inventors: Leo PAVLIV, Ines MACIAS-PEREZ
  • Ifetroban Treatment for Systemic Sclerosis
    Publication number: 20230381147
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 10, 2023
    Publication date: November 30, 2023
    Inventors: Leo PAVLIV, James West, Ines Macias-Perez, Erica Carrier
  • Ifetroban Treatment for Systemic Sclerosis
    Publication number: 20220133696
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: January 14, 2022
    Publication date: May 5, 2022
    Inventors: Leo PAVLIV, James West, Ines Macias-Perez, Erica Carrier
  • METHODS OF TREATMENT OF SOLID TUMORS USING COENZYME Q10
    Publication number: 20220096399
    Abstract: The invention provides methods and compositions for treatment of a subject with a solid tumor comprising administration of Coenzyme Q10 (CoQ10), particularly when the subject has failed at least one prior chemotherapeutic regimen.
    Type: Application
    Filed: May 17, 2021
    Publication date: March 31, 2022
    Applicant: Berg LLC
    Inventors: Niven Rajin Narain, John Patrick McCook, Paul Song, Ines Macias-Perez
  • Ifetroban Treatment for Systemic Sclerosis
    Publication number: 20210015798
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 25, 2020
    Publication date: January 21, 2021
    Inventors: Leo PAVLIV, James West, Ines Macias-Perez, Erica Carrier
  • Ifetroban Treatment for Systemic Sclerosis
    Publication number: 20200253935
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 30, 2020
    Publication date: August 13, 2020
    Inventors: Leo Pavliv, James West, Ines Macias-Perez, Erica Carrier
  • Ifetroban Treatment for Systemic Sclerosis
    Publication number: 20200113872
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 11, 2019
    Publication date: April 16, 2020
    Inventors: Leo PAVLIV, James West, Ines Macias-Perez, Erica Carrier
  • Compositions and Methods of Treating Muscular Dystrophy with Thromboxane-A2 Receptor Antagonists
    Publication number: 20200030298
    Abstract: The present invention is directed to methods of treating and/or ameliorating muscular dystrophy and/or treating cardiomyopathy in muscular dystrophy patients by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist.
    Type: Application
    Filed: September 21, 2019
    Publication date: January 30, 2020
    Inventors: Leo PAVLIV, James WEST, Ines Macias-Perez, Erica Carrier
  • Ifetroban Treatment for Systemic Sclerosis
    Publication number: 20190343809
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 28, 2019
    Publication date: November 14, 2019
    Inventors: Leo PAVLIV, James West, Ines Macias-Perez, Erica Carrier
  • Compositions and methods of treating muscular dystrophy with thromboxane-Areceptor antagonists
    Patent number: 10456380
    Abstract: The present invention is directed to methods of treating and/or ameliorating muscular dystrophy and/or treating cardiomyopathy in muscular dystrophy patients by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: October 29, 2019
    Assignees: CUMBERLAND PHARMACEUTICLS INC., VANDERBILT UNIVERSITY
    Inventors: Leo Pavliv, James West, Ines Macias-Perez, Erica Carrier
  • Compositions and Methods of Treating Muscular Dystrophy with Thromboxane-A2 Receptor Antagonists
    Publication number: 20190142807
    Abstract: The present invention is directed to methods of treating and/or ameliorating muscular dystrophy and/or treating cardiomyopathy in muscular dystrophy patients by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist.
    Type: Application
    Filed: January 4, 2019
    Publication date: May 16, 2019
    Inventors: Leo PAVLIV, James WEST, Ines Macias-Perez, Erica Carrier
  • Ifetroban Treatment for Systemic Sclerosis
    Publication number: 20190117628
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 16, 2018
    Publication date: April 25, 2019
    Inventors: Leo PAVLIV, James West, Ines Macias-Perez, Erica Carrier
  • Compositions and Methods of Treating Muscular Dystrophy with Thromboxane-A2 Receptor Antagonists
    Publication number: 20180353481
    Abstract: The present invention is directed to methods of treating and/or ameliorating muscular dystrophy and/or treating cardiomyopathy in muscular dystrophy patients by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist.
    Type: Application
    Filed: July 31, 2018
    Publication date: December 13, 2018
    Inventors: Leo PAVLIV, James WEST, Ines Macias-Perez, Erica Carrier
  • Compositions and methods of treating muscular dystrophy with thromboxane-Areceptor antagonists
    Patent number: 10064845
    Abstract: The present invention is directed to methods of treating and/or ameliorating muscular dystrophy and/or treating cardiomyopathy in muscular dystrophy patients by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist.
    Type: Grant
    Filed: May 11, 2017
    Date of Patent: September 4, 2018
    Assignees: Cumberland Pharmaceuticals, Inc., Vanderbilt University
    Inventors: Leo Pavliv, James West, Ines Macias-Perez, Erica Carrier
  • Compositions and Methods of Treating Muscular Dystrophy with Thromboxane-A2 Receptor Antagonists
    Publication number: 20170340614
    Abstract: The present invention is directed to methods of treating and/or ameliorating muscular dystrophy and/or treating cardiomyopathy in muscular dystrophy patients by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist.
    Type: Application
    Filed: May 11, 2017
    Publication date: November 30, 2017
    Applicants: Cumberland Pharmaceuticals, Inc., Vanderbilt University
    Inventors: Leo Pavliv, James West, Ines Macias-Perez, Erica Carrier
  • IFETROBAN TREATMENT FOR SYSTEMIC SCLEROSIS
    Publication number: 20170312255
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 27, 2017
    Publication date: November 2, 2017
    Applicants: Cumberland Pharmaceuticals, Inc., Vanderbilt University
    Inventors: Leo Pavliv, James West, Ines Macias-Perez, Erica Carrier
  • METHODS OF TREATMENT OF SOLID TUMORS USING COENZYME Q10
    Publication number: 20170216223
    Abstract: The invention provides methods and compositions for treatment of a subject with a solid tumor comprising administration of Coenzyme Q10 (CoQ10), particularly when the subject has failed at least one prior chemotherapeutic regimen.
    Type: Application
    Filed: October 10, 2016
    Publication date: August 3, 2017
    Inventors: Niven Rajin NARAIN, John Patrick McCook, Paul Song, Ines Macias-Perez
  • METHODS OF TREATMENT OF SOLID TUMORS USING COENZYME Q10
    Publication number: 20140017317
    Abstract: The invention provides methods and compositions for treatment of a subject with a solid tumor comprising administration of Coenzyme Q10 (CoQ10), particularly when the subject has failed at least one prior chemotherapeutic regimen.
    Type: Application
    Filed: May 31, 2013
    Publication date: January 16, 2014
    Inventors: Niven Rajin Narain, John Patrick McCook, Paul Y. Song, Ines Macias-Perez